The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma

Abstract Medullary thyroid carcinoma (MTC) is highly malignant and quite different from the most common papillary thyroid carcinoma (PTC). However, most of the ultrasonic evaluation systems mainly aim at PTC at present. This study aims to evaluate the applicability of modified TI‐RADS in diagnosing...

Full description

Bibliographic Details
Main Authors: Jialin Zhu, Xing Li, Xi Wei, Xueling Yang, Jing Zhao, Sheng Zhang, Zhi Guo
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2217
id doaj-f42bfb51b256460db938fb28fb615bd8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jialin Zhu
Xing Li
Xi Wei
Xueling Yang
Jing Zhao
Sheng Zhang
Zhi Guo
spellingShingle Jialin Zhu
Xing Li
Xi Wei
Xueling Yang
Jing Zhao
Sheng Zhang
Zhi Guo
The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
Cancer Medicine
medullary thyroid carcinoma (MTC)
modified
papillary thyroid carcinoma (PTC)
thyroid
TI‐RADS
author_facet Jialin Zhu
Xing Li
Xi Wei
Xueling Yang
Jing Zhao
Sheng Zhang
Zhi Guo
author_sort Jialin Zhu
title The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
title_short The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
title_full The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
title_fullStr The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
title_full_unstemmed The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
title_sort application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2019-07-01
description Abstract Medullary thyroid carcinoma (MTC) is highly malignant and quite different from the most common papillary thyroid carcinoma (PTC). However, most of the ultrasonic evaluation systems mainly aim at PTC at present. This study aims to evaluate the applicability of modified TI‐RADS in diagnosing MTC and compare the sonographic differences of MTC, PTC, and benign nodules. Three thousand two hundred and forty‐two thyroid nodules images confirmed by pathology were categorized according to modified TI‐RADS and ACR TI‐RADS classification. The performances of two TI‐RADS were assessed by ROC curves. The correlations between classifications with the pathology and the consistency of different doctors were evaluated. The ultrasonic differences of MTC, PTC, and benign nodules were analyzed. As a result, the number of high suspicious US features increased, the malignant risk of nodules also increased of two classifications, with significant differences between categories (P < 0.001). Spearman correlation coefficients were 0.751 (modified TI‐TADS) and 0.744 (ACR TI‐RADS). Areas under the ROC curve of the modified TI‐RADS and ACR TI‐RADS were 0.960 and 0.872 (P < 0.001). At Best cut off points, the diagnostic value of modified TI‐RADS was higher than that of ACR TI‐RADS with a higher specificity, PPV, accuracy, and Youden index). By using modified TI‐RADS to diagnose MTC and PTC, the sensitivity, specificity, NPV, accuracy, and Youden index were higher in MTC than PTC. The Kendall's correlation coefficients were 0.962, 0.930, and 0.987. MTC had special ultrasonography characters compared with PTC and benign nodules. These results suggest that modified TI‐RADS is better than ACR TI‐RADS in diagnosing thyroid carcinomas. Diagnostic value to MTC of modified TI‐RADS is slightly higher than that to PTC, and the categorical results of different doctors were consistent. MTC had several particular features contrast to PTC and benign nodules.
topic medullary thyroid carcinoma (MTC)
modified
papillary thyroid carcinoma (PTC)
thyroid
TI‐RADS
url https://doi.org/10.1002/cam4.2217
work_keys_str_mv AT jialinzhu theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xingli theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xiwei theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xuelingyang theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT jingzhao theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT shengzhang theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT zhiguo theapplicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT jialinzhu applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xingli applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xiwei applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT xuelingyang applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT jingzhao applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT shengzhang applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
AT zhiguo applicationvalueofmodifiedthyroidimagingreportanddatasystemindiagnosingmedullarythyroidcarcinoma
_version_ 1726001248848576512
spelling doaj-f42bfb51b256460db938fb28fb615bd82020-11-24T21:21:04ZengWileyCancer Medicine2045-76342019-07-01873389340010.1002/cam4.2217The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinomaJialin Zhu0Xing Li1Xi Wei2Xueling Yang3Jing Zhao4Sheng Zhang5Zhi Guo6Department of Ultrasound Diagnosis and Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Ultrasound Diagnosis and Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Ultrasound Diagnosis and Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Ultrasound Diagnosis and Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Ultrasound Diagnosis and Treatment, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin ChinaAbstract Medullary thyroid carcinoma (MTC) is highly malignant and quite different from the most common papillary thyroid carcinoma (PTC). However, most of the ultrasonic evaluation systems mainly aim at PTC at present. This study aims to evaluate the applicability of modified TI‐RADS in diagnosing MTC and compare the sonographic differences of MTC, PTC, and benign nodules. Three thousand two hundred and forty‐two thyroid nodules images confirmed by pathology were categorized according to modified TI‐RADS and ACR TI‐RADS classification. The performances of two TI‐RADS were assessed by ROC curves. The correlations between classifications with the pathology and the consistency of different doctors were evaluated. The ultrasonic differences of MTC, PTC, and benign nodules were analyzed. As a result, the number of high suspicious US features increased, the malignant risk of nodules also increased of two classifications, with significant differences between categories (P < 0.001). Spearman correlation coefficients were 0.751 (modified TI‐TADS) and 0.744 (ACR TI‐RADS). Areas under the ROC curve of the modified TI‐RADS and ACR TI‐RADS were 0.960 and 0.872 (P < 0.001). At Best cut off points, the diagnostic value of modified TI‐RADS was higher than that of ACR TI‐RADS with a higher specificity, PPV, accuracy, and Youden index). By using modified TI‐RADS to diagnose MTC and PTC, the sensitivity, specificity, NPV, accuracy, and Youden index were higher in MTC than PTC. The Kendall's correlation coefficients were 0.962, 0.930, and 0.987. MTC had special ultrasonography characters compared with PTC and benign nodules. These results suggest that modified TI‐RADS is better than ACR TI‐RADS in diagnosing thyroid carcinomas. Diagnostic value to MTC of modified TI‐RADS is slightly higher than that to PTC, and the categorical results of different doctors were consistent. MTC had several particular features contrast to PTC and benign nodules.https://doi.org/10.1002/cam4.2217medullary thyroid carcinoma (MTC)modifiedpapillary thyroid carcinoma (PTC)thyroidTI‐RADS